What's Happening?
Warren Buffett has attributed the failure of Haven, the employer coalition he co-founded with JPMorgan Chase and Amazon, to the dynamics within hospital boardrooms. Buffett stated that 'the most prestigious people in the community are on hospital boards,
a lot of people that are fairly happy with the system,' concluding that Haven was 'fighting a tapeworm in the American economy, and the tapeworm won.' This perspective suggests that the entrenched interests and lack of urgency among influential board members, who often benefit from the status quo, hindered efforts to reform the healthcare system. Buffett's insights are informed by direct experience, as Charlie Munger chaired a Los Angeles hospital board for 31 years and Tom Murphy served on NYU Langone's board for five decades, providing Buffett with direct access to hospital boardroom perspectives.
Why It's Important?
Buffett's assessment highlights a critical systemic issue within the U.S. healthcare industry: the lack of accountability and transparency in hospital governance. Employers, who are significant payers in the healthcare system, often renew contracts and accept price increases without scrutinizing the governance structures or cost efficiencies of the hospital systems they fund. This opacity, particularly regarding board rosters and community benefit spending, prevents employers from effectively leveraging their position as counterparties. The current system, where 'prestige is a business model,' allows hospitals to operate with limited external oversight, contributing to rising healthcare costs and a lack of innovation in cost reduction. This situation impacts millions of Americans through higher insurance premiums and out-of-pocket expenses, as employers pass on these costs.
What's Next?
The critique suggests that employers need to adopt a more proactive and organized approach to healthcare purchasing. Instead of passively accepting terms, employers should demand transparency regarding hospital board members, audit community benefit spending, and understand cost structures. Tying preferred provider status and patient steerage to these disclosures could create leverage for change. This shift would require employers to treat board disclosure, community benefit reporting, and contracting terms as interconnected conversations rather than separate issues. While individual employers may struggle to exert influence, collective action or a more unified approach could force healthcare systems to become more accountable and potentially drive down costs. The onus is on employers to organize their leverage and make transparency a condition of their financial contributions.
Beyond the Headlines
The deeper implication of Buffett's observation is that the U.S. healthcare system's resistance to change is not merely a matter of regulation or entrenched incumbents, but a fundamental issue of governance and incentives. The 'prestige' associated with hospital board membership can create a self-perpetuating system that prioritizes institutional self-protection and high prices over efficiency and affordability. This raises ethical questions about the responsibilities of board members and the extent to which their personal interests or comfort with the status quo may impede necessary reforms. The challenge extends beyond healthcare, suggesting that in any sector where powerful, prestigious individuals govern, systemic change can be difficult without external pressure demanding greater accountability and transparency. Addressing this requires a fundamental shift in how stakeholders, particularly major payers like employers, engage with and demand oversight from these powerful institutions.
